drug
etrasimod
Marketedupdated 5mo agoby $PFE PFIZER INC
Approvedcommunity read0 votes
indications
investigational
IBD (Crohn's + UC)
all catalysts(0)
nothing on the calendar yet
Trials studying etrasimod
- —An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis
- phase2A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- phase1A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
- —A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
- phase3An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
- phase2Etrasimod as Prevention of Pouchitis
- phase2A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- phase2Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 12, 2028
~2.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (9)
- Jun 21, 2036compositionUS 10301262
- Jun 21, 2036method-of-use (U-3731)US 10676435
- Jun 21, 2036compositionUS 11091435
- Jun 21, 2036method-of-use (U-3731)US 11884626
- Jan 6, 2036method-of-use (U-3730)US 11007175
- Jan 6, 2036method-of-use (U-4047)US 12156866
- Jan 6, 2036method-of-use (U-4255)US 12377071
- Mar 5, 2030compositionUS 85808413.4y
- Jul 22, 2029method-of-use (U-3732)US 91269322.8y
FDA exclusivities (1)
- Oct 12, 2028NCENew Chemical Entity (5y)2.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that